RALEIGH, N.C., March 21, 2016 -- PRA Health Sciences (PRA) (NASDAQ:PRAH), a leading global contract research organization, is pleased to announce that it has been awarded a 2016 Top Workplaces honor by Philly.com. The Top Workplaces recognition is based solely on the results of an employee feedback survey administered by WorkplaceDynamics, LLC, a leading research firm that specializes in organizational health and workplace improvement.
“We are honored to receive this recognition,” said Tami Klerr, Executive Vice President, Business Development. “At PRA, our employees are what make our company great and it is affirming to see that they are proud of where they work. This award is a testament to the dedication and passion they bring to working in an industry that helps bring life-improving and lifesaving drugs to market.”
In 2015, employees from PRA’s Horsham and Fort Washington facilities relocated to a new state-of-the-art facility in Blue Bell, now the company’s largest office worldwide. PRA has invested more than $4 million in the Blue Bell expansion project and expects to create at least 250 new full-time jobs by the end of 2016. Based on the project’s significant economic impact, the Pennsylvania Department of Community and Economic Development provided PRA with a $750,000 Pennsylvania First Program grant.
“We are hiring in all major divisions, including clinical operations areas and corporate functions,” said Harris Koffer, President, Strategic Solutions Division. “The clinical research industry requires many unique skill sets and we are always looking to attract high caliber talent to join our exceptional team.”
PRA currently has approximately 150 open positions in Philadelphia and the surrounding area. Information about PRA career opportunities can be found at www.DiscoverYourPRA.com.
ABOUT PRA HEALTH SCIENCES
PRA is one of the world's leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East, and approximately 12,000 employees worldwide. Since 2000, PRA has performed approximately 3,300 clinical trials worldwide and has worked on more than 100 marketed drugs across several therapeutic areas. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 60 drugs. To learn more about PRA, please visit www.prahs.com.
INQUIRIES: Christine Rogers, Manager - Public Relations, Corporate Communications EMAIL: [email protected] PHONE: +1 919.786.8463


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 



